NCT03417739 2026-02-25A Phase II Study of BVD-523 in Metastatic Uveal MelanomaDana-Farber Cancer InstitutePhase 2 Terminated13 enrolled 9 charts
NCT02608229 2021-04-21BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic CancerWashington University School of MedicinePhase 1 Terminated18 enrolled 14 charts